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Three Case Reports to Illustrate Clinical Applications in the
Use of Erythrocyte Transketolase
Derrick Lonsdale
24700 Center Ridge Road, Westlake, OH 44145, USA
Non-caloric nutrients (NCN) are extremely numerous and it is more than obvious that they work in a
team relationship. These vitally important interactions are, for the most part, poorly understood. These
brief case reports illustrate this in the therapeutic use of thiamin in a clinical setting. The initially
abnormal erythrocyte transketolase activity (TKA) and/or the thiamin pyrophosphate effect (TPPE),
indicating intracellular cofactor deficiency, usually improves with thiamin administration. Biochemical
correction of the abnormality is, however, invariably dependent on the provision of other NCN,
especially magnesium. In two patients reported here, this correction required several infusions
containing magnesium and other NCN administered intravenously. In a third patient, hemoconcentration
associated with an abnormal TPPE was normalized after administration of nutrients that included
thiamin and magnesium.
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Introduction
All the patients in these case reports were found to have
evidence of intracellular thiamin deficiency by means of
erythrocyte transketolase studies. This was demonstrated
by an abnormally decreased transketolase activity (TKA), an
increased thiamin pyrophosphate effect (TPPE), or both
together. Experience with the administration of thiamin or
thiamin tetrahydrofurfuryl disulfide (TTFD) in patients has
shown that it is usually easy to correct abnormal TKA/TPPE
studies and that it correlates with clinical improvement (1–4).
In two of the three patients reported here, TKA/TPPE studies
became worse in spite of large doses of thiamin and
magnesium given by mouth. Correction of the biochemical
abnormality was not achieved until nutrients were given by
intravenous infusion. In a third patient, symptoms were
accompanied by an abnormal TPPE and hemoconcentration,
both of which became normal with the administration of
TTFD.
Methods
Not many laboratory tests for nutritional deficiency are
performed that depend on enzymatic function. Transketolase
is an enzyme that occurs twice in the hexose monophosphate
shunt and its activity depends on thiamin and magnesium as
cofactors. Because this biochemical pathway occurs in
erythrocytes, the test can be performed on a blood sample
(5,6). It first depends on measuring the baseline speed of
synthesis of the reaction product, sedulose-7-phosphate and
this is reported as TKA in units per liter of blood per
minute. The normal laboratory range for TKA is 42–86 mU
min
 1. The second part of the test depends on the in vitro
addition of thiamin pyrophosphate (TPP), after controlling for
magnesium, and measuring the reaction again. If the synthesis
of the enzyme product accelerates it is reported as the
percentage increase over the baseline rate and referred to as
the TPPE. The normal laboratory range for this is 0–17%.
Case Reports
Case 1
J.S. was a 77-year-old woman. In June 2005, she came to our
clinic complaining of extreme fatigue. This was severe enough
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experiencing occasional ‘dizziness’ on rising in the morning
and severe constipation. She reported that an ophthalmologist
had found increased pressure in one eye and she was using eye
drops prescribed for this. Past history revealed that she had
received radioactive iodine as a child and was being treated
with synthetic T3. Although the TKA was in the normal range
(Fig. 1) the TPPE was 18%, indicating a mild degree of
thiamin deficiency.
She was treated with orally administered nutritional supple-
ments that included a multivitamin, 3 g of ascorbic acid (bowel
tolerance), 300 mg of magnesium/potassium/aspartate, 250 mg
of calcium with 166 mg magnesium in a combination tablet
taken at bedtime, 5 mg of phytonadione (vitamin K1) because
of a history of osteoporosis diagnosed elsewhere, 200 mg of
lipoic acid and 150 mg of TTFD.
Two months later she reported that she had ‘more energy’.
In spite of this the TKA was lower in concentration and the
TPPE had accelerated dramatically (Fig. 1). Although there
was no exacerbation of symptoms, 1 month later the laboratory
results had deteriorated again and it was decided to provide her
with a series of intravenous infusions (Table 1). Following this
treatment, the laboratory test was repeated. The TKA had
increased its activity and the TPPE had fallen to 3% (Fig. 1)
Case 2
F.G. was first seen at the age of 39 years with what he
described as ‘easily pulled muscles on exercise’ and fatigue. A
constant complaint over the years was carpo pedal spasms and
occasional hypogastric discomfort, also often associated with
exercise. With a recent office visit, at the age of 56 years he
admitted to constant dietary indiscretions with simple carbo-
hydrates. Because of an abnormal TPPE (Fig. 2) the nutrients
provided included TTFD and magnesium/potassium/aspartate,
p.o. He was seen again 2 months later and there had been no
change in symptoms. The TPPE had increased although TKA
had improved in activity (Fig. 2). Between January 10 and
16 he received four of the same nutrient infusions given to the
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Figure 2. TKA/TPPE Case 2.
Table 1. Contents of the intravenous infusions given to J.S.
Sodium chloride 0.9% 250 ml
Magnesium chloride 2 g 10 ml
Calcium gluconate 10% 10 ml
Pyridoxine 100 mg 1 ml
Dexpanthenol 1 g 4 ml
Hydroxocobalamin 1 mg 1 ml
Ascorbic acid 6 g 12 ml
248 Clinical Applications in the use of erythrocyte transketolasepatient in Case 1 (Table 1). During this period of administering
the infusions, his symptoms disappeared, but began to return
after their completion. The TKA had again increased and the
TPPE had decreased into the acceptable range of normal.
Case 3
J.K. This 72-year-old woman was first seen because of
‘flu-like’ symptoms that occurred every 2 weeks after square
dancing. She would feel chilled, experience nausea and
become unusually fatigued. Low-grade fever would last about
4 days. She would feel well again until after the next session of
dancing. She reported recurrent sinus infections that had
occurred over a number of years, each being treated with an
antibiotic.
Laboratory studies are shown in Table 2 before and after
2 months of nutrient therapy. Dietary counseling and supple-
mentation correlated with clinical improvement. Supplements
included a multivitamin as a nutritional foundation, up to 3 g
of ascorbic acid, depending on bowel tolerance, 240 mg EPA,
60 mg GLA, B complex with 50 mg additional pyridox-5-
phosphate, 270 mg magnesium and 270 mg of potassium as
magnesium/potassium/aspartate and 150 mg TFFD.
Discussion
Theoretically, the transketolase enzyme should be saturated
with TPP and there should be no acceleration of its activity
after the addition of TPP. The percentage acceleration should
be thought of as a gradual transition from thiamin sufficiency
to deficiency. The result of the test is at its worst when the
TKA is below the laboratory range and the TPPE is increased
over the acceptable range of 17%. Moderate deficiency may be
recorded with a TKA in the normal laboratory range and an
abnormal increase in TPPE. Although the test is usually used
exclusively for evidence of intracellular thiamin deficiency
(3–6), an increased activity of TKA was reported as being able
to distinguish B12-deficient from folate-deficient pernicious
anemia (7). It also should be possible to use the test for
magnesium deficiency by controlling for TPP, but this has
never been done to my knowledge.
It has long been known that magnesium and thiamin have a
close biochemical relationship. Itokawa et al. (8) found that
tissue TKA decreased markedly in thiamin-deficient (TD) and
thiamin–magnesium-deficient (TMD) rats. Addition of TPP to
tissue homogenates of TD rats resulted in recovery of TKA .
This did not occur when rats were also deficient in magnesium.
In subcellular fractions of the liver of magnesium-deficient
rats thiamin content was most markedly decreased in the
mitochondrial fraction (9). Fujiwara et al. (10) showed that
both calcium and magnesium are important components of a
diet aimed at providing adequate thiamin nutrition. Jung et al.
(11) studied the binding kinetics for [
35S] TPP to transketolase
and the dependency of the enzyme on divalent cations for
activity. They showed that transketolase contained Mg
2þ in its
molecular structure.
Itokawa et al. (12) suggested that excess thiamine promotes
magnesium deficiency and liberates serotonin into the blood
stream from mast cells. In thiamin-excess with magnesium
deficiency and in thiamine-adequate, magnesium-deficient
rats, serotonin oxidation activity in liver and stomach
decreased significantly, while this decrease was not observed
in thiamine-deficient, magnesium-deficient rats (13). Liver
cholesterol and lipid levels in thiamine-adequate magnesium-
deficient and in thiamine-excess magnesium-deficient rats
increased significantly (14). Basic science studies indicate that
a physiological concentration of Mg
2þ can regulate TPP
binding to the thiA riboswitch (15). Coenzymes exert their
catalytic activity after binding to a specific protein component,
another variable in showing correction of TKA abnormalities
(16). Although the free coenzyme TPP can assist some of its
coenzyme reaction, the protein environment potently acceler-
ates the overall enzyme reaction by up to a factor of 10
12 (17).
Thus, there may be genetically determined factors that
complicate thiamin therapy.
The intimate relationship of thiamin and magnesium was
demonstrated clinically in a patient with Crohn’s disease.
Long-standing diarrhea resulted in combined thiamin and
magnesium deficiency. Despite massive doses of thiamin
administered intravenously, the symptoms of thiamin defi-
ciency could not be relieved until correction of the magnesium
deficiency (18). Wernicke encephalopathy, a well known
result of thiamin deficiency, has been reported as being
induced by magnesium deficiency (19).
Fifty patients with abnormal transketolase activity coeffi-
cient (ETK-AC) and affinity for coenzyme (Km-TPP)
had associated fibromyalgia or senile dementia of Alzheimer
type (20). Compared with 12 untreated patients, ETK-AC was
significantly decreased with administration of thiamin and
pyridoxine. The Km-TPP was significantly decreased with
high energy phosphates or piracetam. In 9 other patients
treated with a combination of high energy phosphates,
vitamins B1, B6, and magnesium, ETK-AC and Km-TPP
were both significantly decreased.
It is to be noted that the patient J.S. (Case 1) had been found
to have increased pressure in one eye and was being treated
with eye drops by an ophthalmologist. Evidence exists that
autonomic nervous system dysfunction ispresent inopen angle
glaucoma, resulting in disturbed autoregulation, leading to
vascular dysregulation in the eye (21,22). Cold provocation
in patients with this form of glaucoma produced different
blood pressure responses and ocular blood flow response as
compared with controls (23), suggesting that environmental
stress might play a part. Thiamin deficiency has long been
known to cause autonomic nervous system dysfunction (24).
Table 2. Laboratory studies: Case 3
TKA
(mu)
TPPE (%) RBC
(mill mcl
 1)
Hb
(g dl
 1)
Hematocrit
(%)
September 46 33 5.36 15.7 46.1
November 77 3 4.5 14 41.3
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nutritional supplements by mouth while the TKA/TPPE results
became worse. They improved rapidly into the normal range
after magnesium, with other non-caloric nutrients (NCN), was
given intravenously. Ascorbic acid has been shown to activate
thiamin diphosphatase in rat brain (25) The studies discussed
here show that magnesium is of vital importance in the normal
TKA/TPPE combination, but some of them suggest that TKA
is dependent on a number of nutrient variables. Also, this
laboratory test only shows a particular aspect of thiamin
metabolism and does nothing to expose a failure to synthesize
thiamin triphosphate, so important in the central nervous
system (26).
The hemoconcentration associated with thiamin deficiency
in the patient in Case 3 requires comment. Erythrocytosis has
been observed in TD rats (27). The number of reticulocytes
and plasma erythropoietin levels increased and the levels of
2,3-diphosphoglycerate of RBCs decreased. A Medline search
failed to reveal any similar observation in humans. Oxygen-
chemosensitive sites are distributed throughout the brainstem
from the thalamus to the medulla and may form an oxygen-
chemosensitive network (28), although these authors empha-
sized that little is known regarding the cellular mechanisms
involved in the chemotransduction process of the central
oxygen sensors.
Experimentally induced hypoxia in rats induced poly-
cythemia (29), a phenomenon that is usually considered as a
compensatory effect. Increase in erythropoietin appears to be
the mechanism (30).
Although the referenced research is related to the study of
high-altitude compensatory physiology, it is possible that
thiamin deficiency might imitate high altitude by its effect on
brainstem. The recurrent ‘flu-like’ symptoms experienced by
JS after physical activity might have been the equivalent of
recurrent mountain sickness. Adaptation at the cellular level
involves a shift from oxidative phosphorylation to anaerobic
glycolysis, increased glucose metabolism and expression of
hypoxic stress-related proteins. Thiamin biochemistry, meta-
bolism and pathophysiology was recently reviewed (31). It
was pointed out that the role of the vitamin in brain function is
still incompletely understood, particularly in the form of
thiamin triphosphate. Until it becomes possible to detect this
vital component by clinical laboratories, its deficiency cannot
be detected easily.
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